Aclara BioSciences, BD Biosciences | GenomeWeb

Aclara BioSciences has launched an expanded set of eTag gene-expression assays, which include 11 different pre-formatted and validated panels of genes that range in the number of genes monitored from six to 24. In addition to these gene panels, the company has assembled a collection of assays for other individual genes involved in drug toxicity that can be configured into multi-gene panels. In the ADME/Tox area, this collection comprises around 300 human genes and 100 rat genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.